Skip to Main Content
1440_405-1116_628-768_432

Neuroscience Update 2022: Insights & Innovations

The Northern California Neuroscience Symposium: Insights & Innovations is back!

Physicians, physician assistants, nurse practitioners, registered nurses, and pharmacists this educational activity is for you. Come and listen to lectures from the Neuroscience Institute's multiple sclerosis, migraine treatment, and epilepsy experts. Learners will have the opportunity to work through cases in real-time with the physicians and their colleagues in small group discussions. Take advantage of asking the experts your most burning questions.

After completing this educational activity, the learners should be able to consider the impact of disease-modifying therapies on vaccinations schedules in order to monitor patient safety of multiple sclerosis treatment plans; recognize signs and symptoms of multiple sclerosis relapses versus pseudorelapses and serious side effects of medications used in multiple sclerosis to prompt appropriate testing; differentiate seizure disorders from other diagnoses; prescribe acute and preventative CGRP-targeted therapy for the treatment of migraine; identify when to refer a patient to an epileptologist for video EEG monitoring and a higher level of care. Learners will leave this symposium with new strategies to identify and treat multiple sclerosis, epilepsy, and migraine at the earliest stages. 

Event Details 

REGISTER HERE

October 15, 2022
7:30 a.m. to 1:00 p.m.

Location:  Hyatt Regency Sacramento
1209 L Street
Sacramento, CA

Agenda:

7:30 a.m. Exhibit Hall
8:00 a.m. Welcome, Featured Presentations
12:00 p.m. Network
1:00 p.m. Closing Remarks/Adjourn

Our featured presentations will include:

Update on Diagnosis of Multiple Sclerosis and Multiple Sclerosis Spectrum Disorders
Yelena Usmanova, MD, MSC

Management of Multiple Sclerosis
Sabeen Lulu MD, MCR |  Assistant Clinical Professor of Neurology | Director, Mercy MS Center

Seizures & Epilepsy: A Practical Approach for the Primary Care Setting
Hemant Kudrimoti, MD, Ph.D. | Neurologist, Mercy Medical Group, Sacramento, CA

Epilepsia - 21st Century Treatment Options for an Ancient Disease
Edwin A. Cruz, MD

Advances in Migraine Management: The Rise of CGRP-targeted Therapies
David Walker, MD


Accreditation Statement:

In support of improving patient care, Dignity Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider Number: 4004043

Provider Designee/Verification: Monica Bourke, MSN, RN

This activity was planned by and for the healthcare team, and learners will receive 4 Interprofessional Continuing Education (IPCE) credits for learning and change. 

Physicians - Dignity Health designates this activity for a maximum of 4 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Nurses - This program has been awarded 4 ANCC contact hours by Dignity Health. Nurses should claim only credit commensurate with the extent of their participation in the activity.

Nurses - This program has been approved for 4 contact hours by the California Board of Registered Nursing – Provider Number 17375

Physician Assistants - Dignity Health has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 4 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation. 

 

Pharmacy - Dignity Health designates this knowledge-based activity for 4 ACPE credits. This is not a valid statement of credit. Credit for pharmacists and technicians will be uploaded into CPE Monitor and will be available within 60 days post activity pending submission of individual NAPB (EPID) number and DOB (Mo/Day)